Newbridge Financial Services Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-6,650
| Closed | -$2.39K | – | 1473 |
|
|
2023
Q1 | $2.39K | Hold |
6,650
| – | – | ﹤0.01% | 1174 |
|
|
2022
Q4 | $5.89K | Hold |
6,650
| – | – | ﹤0.01% | 1032 |
|
|
2022
Q3 | $10K | Hold |
6,650
| – | – | 0.01% | 898 |
|
|
2022
Q2 | $13K | Hold |
6,650
| – | – | 0.01% | 795 |
|
|
2022
Q1 | $15K | Sell |
6,650
-750
| -10% | -$1.69K | 0.01% | 823 |
|
|
2021
Q4 | $34K | Sell |
7,400
-12,925
| -64% | -$59.4K | 0.02% | 579 |
|
|
2021
Q3 | $155K | Buy |
20,325
+2,275
| +13% | +$17.3K | 0.1% | 203 |
|
|
2021
Q2 | $175K | Buy |
18,050
+1,000
| +6% | +$9.7K | 0.11% | 195 |
|
|
2021
Q1 | $141K | Sell |
17,050
-5,500
| -24% | -$45.5K | 0.1% | 207 |
|
|
2020
Q4 | $154K | Sell |
22,550
-4,350
| -16% | -$29.7K | 0.13% | 169 |
|
|
2020
Q3 | $300K | Buy |
+26,900
| New | +$300K | 0.3% | 75 |
|